Armistice Capital’s Verastem VSTM Stock Holding History

Armistice Capital’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.8M	Buy	7,024,000 +2,432,000	+53%	+$11.8M	0.33%	49
2026 Q1	$24.3M	Buy	4,592,000 +1,056,000	+30%	+$6.51M	0.43%	45
2025 Q4	$27.3M	Buy	3,536,000 +1,440,000	+69%	+$12.8M	0.32%	49
2025 Q3	$18.5M	Sell	2,096,000 -40,000	-2%	-$298K	0.27%	56
2025 Q2	$8.86M	Buy	+2,136,000	New	+$13.4M	0.15%	73
2024 Q4	–	Sell	-1,364,000	Closed	-$4.08M	–	302
2024 Q3	$4.08M	Buy	+1,364,000	New	+$3.7M	0.07%	131
2023 Q2	–	Sell	-166,667	Closed	-$830K	–	270
2023 Q1	$830K	Hold	166,667	–	–	0.01%	145
2022 Q4	$805K	Hold	166,667	–	–	0.01%	135
2022 Q3	$1.7M	Hold	166,667	–	–	0.03%	127
2022 Q2	$2.32M	Hold	166,667	–	–	0.04%	113
2022 Q1	$2.82M	Hold	166,667	–	–	0.05%	93
2021 Q4	$4.1M	Hold	166,667	–	–	0.07%	114
2021 Q3	$6.16M	Buy	+166,667	New	+$6.12M	0.1%	102

Other funds holding VSTM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

FCMV

Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return

Armistice Capital's VSTM Position: Q2 2026 in Review

Armistice Capital increased its Verastem (VSTM) stake by 53% in Q2 2026, buying an estimated $11.8M and bringing the position to 7,024,000 shares worth $26.8M. The position accounts for 0.33% of the portfolio, ranked #49.

Armistice Capital first reported a position in VSTM in Q3 2021 and has held it in 13 quarters since. The position peaked at $27.3M in Q4 2025. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

Armistice Capital held 7,024,000 shares of Verastem worth $26.8M as of Q2 2026.
Armistice Capital bought 2,432,000 Verastem shares in Q2 2026, an estimated $11.8M.
Verastem made up 0.33% of Armistice Capital's portfolio in Q2 2026, its #49 holding.
Armistice Capital first reported a position in Verastem in Q3 2021 and has held it in 13 quarters since.
Armistice Capital's Verastem position peaked at $27.3M in Q4 2025.
157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.